• Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
Money Profit News
No Result
View All Result
Home Breaking News

Biden expected to pick former FDA Commissioner Dr. Robert Califf to run the agency

by
November 12, 2021
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Related Posts

Stock futures fall following a major comeback week for stocks

Time is ripe to snap up bargains, says debt investor Howard Marks

Monday: Durable Goods, Pending Home Sales, Dallas Fed Mfg

Robert Kiyosaki says that hot inflation will ‘wipe out 50% of the US population’ — here’s what he means by that and how to protect yourself

Dr. Robert Califf testifies during his nomination hearing before the Senate Health, Education, Labor and Pensions Committee November 17, 2015 in Washington, DC.

Win McNamee | Getty Images

President Joe Biden is expected to pick Dr. Robert Califf to serve as the chief of the Food and Drug Administration, NBC News reported Friday, citing people familiar with the selection process.

The FDA, currently overseen by acting Commissioner Dr. Janet Woodcock, has been without a permanent chief since Biden took office in January. The White House reportedly ruled out Woodcock after she faced opposition from some members of Congress over her handling of opioids while at the agency.

Califf, a cardiologist who works at the Duke University School of Medicine, was briefly the agency’s commissioner under the Obama administration beginning in 2016. He also served as deputy commissioner of the FDA’s medical products and tobacco office.

The new selection is expected imminently because Woodcock cannot legally stay on as the acting head past Nov. 15 without a nominee to hold the position permanently.

Biden’s expected nomination comes amid the ongoing Covid-19 pandemic, which has killed at least 759,678 Americans, according to data compiled by Johns Hopkins University.

The FDA has helped bring lifesaving treatments to the market and authorized the use of Covid vaccines, which have shown to be highly effective, especially against severe disease, hospitalization and death.

More than 194 million Americans are fully vaccinated against Covid, according to data compiled by the Centers for Disease Control and Prevention.

The FDA has recently come under harsh criticism, though, over its decision to approve Biogen’s Alzheimer’s drug, Aduhelm.

Next Post

Why This IBM Spinoff Is Struggling

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Popular Posts

Breaking News

Stock futures fall following a major comeback week for stocks

by
June 26, 2022
0

Traders on the floor of the NYSE, June 15, 2022. Source: NYSE U.S. stock futures were little changed on Sunday...

Read more

Stock futures fall following a major comeback week for stocks

Time is ripe to snap up bargains, says debt investor Howard Marks

Monday: Durable Goods, Pending Home Sales, Dallas Fed Mfg

Metals Haven’t Crashed This Hard Since the Great Recession

‘A cold dark place’ — Michael Burry thinks the market has plenty of room to plunge. But he finally sees value in these 4 stocks

Robert Kiyosaki says that hot inflation will ‘wipe out 50% of the US population’ — here’s what he means by that and how to protect yourself

Load More

All rights reserved by www.moneyprofitnews.com

  • Home
  • Breaking News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

moneyprofitnews